5246522025-01-012025-03-315246522025-03-315246522024-03-315246522024-04-012025-03-315246522025-01-012025-03-31in-capmkt:OtherExpenses1Member5246522024-04-012025-03-31in-capmkt:OtherExpenses1Member5246522025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15246522024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15246522025-01-012025-03-31RelatedPartyTransactionDomain15246522024-12-31RelatedPartyTransactionDomain15246522025-03-31RelatedPartyTransactionDomain15246522025-01-012025-03-31RelatedPartyTransactionDomain25246522024-12-31RelatedPartyTransactionDomain25246522025-03-31RelatedPartyTransactionDomain25246522025-01-012025-03-31RelatedPartyTransactionDomain35246522024-12-31RelatedPartyTransactionDomain35246522025-03-31RelatedPartyTransactionDomain35246522025-01-012025-03-31RelatedPartyTransactionDomain45246522024-12-31RelatedPartyTransactionDomain45246522025-03-31RelatedPartyTransactionDomain45246522025-01-012025-03-31RelatedPartyTransactionDomain55246522024-12-31RelatedPartyTransactionDomain55246522025-03-31RelatedPartyTransactionDomain55246522025-01-012025-03-31RelatedPartyTransactionDomain65246522024-12-31RelatedPartyTransactionDomain65246522025-03-31RelatedPartyTransactionDomain65246522025-01-012025-03-31RelatedPartyTransactionDomain75246522024-12-31RelatedPartyTransactionDomain75246522025-03-31RelatedPartyTransactionDomain75246522025-01-012025-03-31RelatedPartyTransactionDomain85246522024-12-31RelatedPartyTransactionDomain85246522025-03-31RelatedPartyTransactionDomain85246522025-01-012025-03-31RelatedPartyTransactionDomain95246522024-12-31RelatedPartyTransactionDomain95246522025-03-31RelatedPartyTransactionDomain95246522025-01-012025-03-31RelatedPartyTransactionDomain105246522024-12-31RelatedPartyTransactionDomain105246522025-03-31RelatedPartyTransactionDomain105246522025-01-012025-03-31RelatedPartyTransactionDomain115246522024-12-31RelatedPartyTransactionDomain115246522025-03-31RelatedPartyTransactionDomain115246522025-01-012025-03-31RelatedPartyTransactionDomain125246522024-12-31RelatedPartyTransactionDomain125246522025-03-31RelatedPartyTransactionDomain125246522025-01-012025-03-31RelatedPartyTransactionDomain135246522024-12-31RelatedPartyTransactionDomain135246522025-03-31RelatedPartyTransactionDomain135246522025-01-012025-03-31RelatedPartyTransactionDomain145246522024-12-31RelatedPartyTransactionDomain145246522025-03-31RelatedPartyTransactionDomain145246522025-01-012025-03-31RelatedPartyTransactionDomain155246522024-12-31RelatedPartyTransactionDomain155246522025-03-31RelatedPartyTransactionDomain155246522025-01-012025-03-31RelatedPartyTransactionDomain165246522024-12-31RelatedPartyTransactionDomain165246522025-03-31RelatedPartyTransactionDomain165246522025-01-012025-03-31RelatedPartyTransactionDomain175246522024-12-31RelatedPartyTransactionDomain175246522025-03-31RelatedPartyTransactionDomain175246522025-01-012025-03-31RelatedPartyTransactionDomain185246522024-12-31RelatedPartyTransactionDomain185246522025-03-31RelatedPartyTransactionDomain185246522025-01-012025-03-31RelatedPartyTransactionDomain195246522024-12-31RelatedPartyTransactionDomain195246522025-03-31RelatedPartyTransactionDomain195246522025-01-012025-03-31RelatedPartyTransactionDomain205246522024-12-31RelatedPartyTransactionDomain205246522025-03-31RelatedPartyTransactionDomain205246522025-01-012025-03-31RelatedPartyTransactionDomain215246522024-12-31RelatedPartyTransactionDomain215246522025-03-31RelatedPartyTransactionDomain215246522025-01-012025-03-31RelatedPartyTransactionDomain225246522024-12-31RelatedPartyTransactionDomain225246522025-03-31RelatedPartyTransactionDomain225246522025-01-012025-03-31RelatedPartyTransactionDomain235246522024-12-31RelatedPartyTransactionDomain235246522025-03-31RelatedPartyTransactionDomain235246522025-01-012025-03-31RelatedPartyTransactionDomain245246522024-12-31RelatedPartyTransactionDomain245246522025-03-31RelatedPartyTransactionDomain245246522025-01-012025-03-31RelatedPartyTransactionDomain255246522024-12-31RelatedPartyTransactionDomain255246522025-03-31RelatedPartyTransactionDomain255246522025-01-012025-03-31RelatedPartyTransactionDomain265246522024-12-31RelatedPartyTransactionDomain265246522025-03-31RelatedPartyTransactionDomain265246522025-01-012025-03-31RelatedPartyTransactionDomain275246522024-12-31RelatedPartyTransactionDomain275246522025-03-31RelatedPartyTransactionDomain275246522025-01-012025-03-31RelatedPartyTransactionDomain285246522024-12-31RelatedPartyTransactionDomain285246522025-03-31RelatedPartyTransactionDomain285246522025-01-012025-03-31RelatedPartyTransactionDomain295246522024-12-31RelatedPartyTransactionDomain295246522025-03-31RelatedPartyTransactionDomain295246522025-01-012025-03-31RelatedPartyTransactionDomain305246522024-12-31RelatedPartyTransactionDomain305246522025-03-31RelatedPartyTransactionDomain305246522025-01-012025-03-31RelatedPartyTransactionDomain315246522024-12-31RelatedPartyTransactionDomain315246522025-03-31RelatedPartyTransactionDomain315246522025-01-012025-03-31RelatedPartyTransactionDomain325246522024-12-31RelatedPartyTransactionDomain325246522025-03-31RelatedPartyTransactionDomain325246522025-01-012025-03-31RelatedPartyTransactionDomain335246522024-12-31RelatedPartyTransactionDomain335246522025-03-31RelatedPartyTransactionDomain335246522025-01-012025-03-31RelatedPartyTransactionDomain345246522024-12-31RelatedPartyTransactionDomain345246522025-03-31RelatedPartyTransactionDomain345246522025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares524652INDSWFTLTDNOTLISTEDINE788B01028IND-SWIFT LIMITEDMain BoardEquity2024-04-012025-03-312025-06-252025-06-19INRLakhsQuarterlyFourth quarterSingle segmentPharmaceuticals2025-06-2515:30:002025-06-2517:00:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2025-02-11www.indswiftltd.comfalsefalseNot Applicable2025-01-012025-03-31AuditedStandalone14490380008650300015355410005781820009090100042272000241974000101753000717200005246010001651403000-11586200027264050002610543000445570000445570000256598600000002565986000506180002616604000108329000247.3747.370047.3747.371 The above financial results have been prepared in accordance with IND-AS prescribed under section 133 of Companies Act,2013 and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI (Listing obligations and Disclosure Requirements) Regulation 2015. <BR> 2 The Company has filed second Motion Petition for approval of scheme of arrangement for Amalgamation of the Ind Swift Limited with Ind Swift Laboratories Ltd, before The Hon'ble National Company Law Tribunal (NCLT) Chandigarh. The Hon'ble National Company Law Tribunal has heard the petition and has reserved the order. <BR> 3 Exceptional/Extraordinary items for this quarter is Rs. 27264.05 and for the year ended 31st March,2025 is 27996.51 lacs includes balance written back/written off (net credit) being not payable/receivable. <BR> 4 During the Year the Company has completed the transfer of Unit No III to ANG Lifescience Ltd and profit on Sale of the same of Rs. 2872.81 lacs is reflected under the head Other Income in the above Result. <BR> 5 The figures for quarter ended March31,2025 and March31,2024 are the balancing figures between the audited figures in respect of full financial year and the published figures of nine months ended December 31,2024 and December 31,2023 respectively. <BR> 6 The Company is exclusively in Pharmaceutical business. <BR> 7 Previous period/ year figures have been re-grouped/Re-arranged where ever necessary. <BR> 8 The above audited Standalone financial results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on 25th June, 2025. <BR> 2024-04-012025-03-31AuditedStandalone515233900047616600056285050002245596000459826000-1036230009180990003915780002350180001402593000554908700079418000279965100028790690004455700004455700002834512000000028345120005061800028851300001083290002-413160900052.3352.330052.3352.33Other Expenses524601000Other Expenses14025930002319857000010681200056606000075096900080757500047016000328126000010724930000158678000069510200000113051000239493300053085500039982810007279541000108329000-4131609000-4023280000-4023280000832103800008321038000979790007468600084937030004164360005873500096154500010202800007772100015144370001278362000163190002809118000113028210007279541000391578000-431578000-820600000-64240000-3672600000000373653000023501800003454700000000537460000-287304000000-27996510000-2720509000158560000000001585600000000000004072120000000000000038574500000000053746000003227900000000000275972000173390000039276100007023000-12710500063734000063734000631368000695102000Items that will not be classified to Profit & Loss5061800050618000Items that will not be classified to Profit & Loss506180005061800000005061800050618000IND SWIFT LIMITED******ESSIX BIOSCIENCES LIMITED******Group CompanyPurchase of goods or services100000000100028792000028792000IND SWIFT LIMITED******ESSIX BIOSCIENCES LIMITED******Group CompanySale of goods or services10000000010003720000345000IND SWIFT LIMITED******ESSIX BIOSCIENCES LIMITED******Group CompanyInvestment0Investment limit is approved by the Board/Shareholders01260700056606000Investments are valued at fair value on the basis of book value as per the last audited annual accounts of investee companies available with the company i.e for the year ending 31.03.2024IND SWIFT LIMITED******IND SWIFT LABORATORIES LIMITED******Group CompanySale of goods or services12000000001200010131000110240000IND SWIFT LIMITED******IND SWIFT LABORATORIES LIMITED******Group CompanyLoan60000000006000017025600036971930003867449000IND SWIFT LIMITED******IND SWIFT LABORATORIES LIMITED******Group CompanyLoan600000000060000046317460004631746000IND SWIFT LIMITED******IND SWIFT LABORATORIES LIMITED******Group CompanyAny other transactionAdvance from customer1200000000120004641160000464116000IND SWIFT LIMITED******IND SWIFT LABORATORIES INC******Subsidiary of Group CompanySale of goods or services2500000002500763890006568300018192000IND SWIFT LIMITED******ELAN VITAL DRUG STORE LLC******LLC incorporated by relative of directorSale of goods or services250000000250030361000829700033039000IND SWIFT LIMITED******ELAN VITAL DRUG STORE LLC******LLC incorporated by relative of directorPurchase of goods or services250000000250028260001580002373000IND SWIFT LIMITED******FORTUNE (INDIA) CONSTRUCTIONS LIMITED******Group CompanyLoan1000000001000319300031930000IND SWIFT LIMITED******SWIFT FUNDAMENTAL RESEARCH AND EDUCATION SOCIETY******Directors are trustees in the societyLoan7000000007000628924000628924000628924000IND SWIFT LIMITED******MUNJAL JAIN ESTATES PRIVATE LIMITED******Relative of director is promoter and director of the companyLoan100000000100024530005376400051311000Including Interest Credited of Rs. 20.47 Lacs (Net of TDS) and repayment of Rs. 45 LacsIND SWIFT LIMITED******DR. GOPAL MUNJAL******Promoter and Managing Director and CEOAny other transactionAdvance against salaryIn terms with the company's HR policy03457900034579000IND SWIFT LIMITED******SH. SANJEEV RAI MEHTA******Promoter and chairmanAny other transactionAdvance against salaryIn terms with the company's HR policy03631900036319000IND SWIFT LIMITED******DR. VIKRANT RAI MEHTA******Promoter and Joint Managing DirectorAny other transactionAdvance against salaryIn terms with the company's HR policy03561800035618000IND SWIFT LIMITED******3M ADVERTISERS AND PUBLISHERS LIMITED******Group CompanyAny other transactionCreditors/payables5000000050002000020000IND SWIFT LIMITED******SH. ANNIE MEHTA******Relative of promoterRemuneration3000000Within the maximum limit as approved by the Audit Committee and Board150700000IND SWIFT LIMITED******CHDMM TIBBI OMEHTA******LLC incorporated by relative of directorSale of goods or services5000000050037542000036625000IND SWIFT LIMITED******CHDMM TIBBI OMEHTA******LLC incorporated by relative of directorRemuneration500000005002016000289520000IND SWIFT LIMITED******DR. GOPAL MUNJAL******Promoter and Managing Director and CEORemuneration18000000Upto 50 Lacs per month899900000IND SWIFT LIMITED******SH. SANJEEV RAI MEHTA******Promoter and chairmanRemuneration18000000Upto 50 Lacs per month900000000IND SWIFT LIMITED******DR. VIKRANT RAI MEHTA******Promoter and Joint Managing DirectorRemuneration18000000Upto 50 Lacs per month899900000IND SWIFT LIMITED******SH. NR MUNJAL******Promoter and Non- Executive DirectorAny other transactionSitting FeesWithin the maximum limit as approved by the Audit Committee and Board36000180000IND SWIFT LIMITED******SH. HIMANSHU JAIN******Promoter and Non- Executive DirectorAny other transactionSitting FeesWithin the maximum limit as approved by the Audit Committee and Board52000200000IND SWIFT LIMITED******SH. RISHAV MEHTA******Promoter and Non- Executive DirectorAny other transactionSitting FeesWithin the maximum limit as approved by the Audit Committee and Board36000180000IND SWIFT LIMITED******Sh. SUBODH GUPTA******Independent DirectorAny other transactionSitting FeesWithin the maximum limit as approved by the Audit Committee and Board4900000IND SWIFT LIMITED******SH. SC GALHOTRA******Independent DirectorAny other transactionSitting FeesWithin the maximum limit as approved by the Audit Committee and Board5800000IND SWIFT LIMITED******SH. BHUPINDER SINGH******Independent DirectorAny other transactionSitting FeesWithin the maximum limit as approved by the Audit Committee and Board6500000IND SWIFT LIMITED******SH. JS AHLUWALIA******Independent DirectorAny other transactionSitting FeesWithin the maximum limit as approved by the Audit Committee and Board5400000IND SWIFT LIMITED******SMT. ANOOP MICHRA******Independent DirectorAny other transactionSitting FeesWithin the maximum limit as approved by the Audit Committee and Board5400000IND SWIFT LIMITED******SH. PRBHAT KHURANA******Independent DirectorAny other transactionSitting FeesWithin the maximum limit as approved by the Audit Committee and Board5000000IND SWIFT LIMITED******SH. ARUN KUMAR SETH******Chief Financial officerRemuneration2000000The limit is approved by NRC/Board90700000IND SWIFT LIMITED******Sh. Puneet Khurana******Company SecretaryRemuneration1000000The limit is approved by NRC/Board395000001487632000AuditedtrueJAIN & ASSOCIATEStrue2026-04-30